Illumina Company Updates | Glassdoor

Company Updates

  • On the Illumina News Center: How next-generation sequencing is helping to fight infectious diseases such as the Coronavirus.

  • On #WorldCancerDay, learn how next-generation sequencing can remove the uncertainty of cancer, so you can focus on your future.

  • We are proud to announce that today, Illumina was included on two prestigious lists that recognize organizations demonstrating leadership in diversity and inclusion: Bloomberg Gender Equality Index (GEI) and the Human Rights Campaign Corporate Equality Index (CEI). We are inspired that our diversity, inclusion, and fairness initiative continues to build opportunities to strengthen the relationship between our employees, our company and our communities. #CEI2020 #BloombergGEI

  • We're pleased to announce a ground-breaking partnership with Roche to broaden the adoption of distributable NGS-based testing in oncology. This agreement brings together complementary capabilities of each company to broaden global adoption of NGS in cancer care. As part of this agreement, Illumina will grant Roche rights to develop and distribute in-vitro diagnostic (IVD) tests on Illumina’s NextSeq™ 550Dx System, as well as the forthcoming NovaSeqDx. Illumina and Roche will develop tests and pursue CDx claims on TruSight Oncology 500 for both existing and pipeline oncology targeted therapies on the NextSeq 550Dx System. Together we will catalyze the genomics ecosystem and advance access to genomic testing to improve patient outcomes.

  • With greater capacity for ground breaking discoveries, simplified workflows, reduced sequencing costs, and advanced flexibility to support new and emerging applications, what will you discover? #ExperienceNextSeq2000

  • “I believe that eDNA will become a key source of data that enables us to make informed conservation decisions - and let’s face it - given the challenges we face in our oceans, rivers and land, it is a time when making good decisions really matters,” - Professor Bunce. From the largest mammals to the smallest phytoplankton, Environmental DNA (eDNA) sequencing is a rapidly emerging method for studying biodiversity and monitoring ecosystem changes in our oceans. Learn more about how Australian Professor Michael Bunce is “Sequencing of the Seas” and giving students a unique experience that helps to connect them to their local beaches.

  • The end of the year is always a time to reflect on accomplishments and goals. Illumina closed out 2019 with a special presentation that reminds us why we all get out of bed every day to pursue the mission of unlocking the power of the genome. Bryce Olson, founder of the Sequence Me movement, inspired us all with his story of how genomic sequencing saved his life, giving us all perspective on what we do. From manufacturing to marketing, from research to accounting, Illumina employees move our mission forward each and every day of the year. As we close out the decade, we want to thank all our employees, contractors, customers and fans from around the globe for pushing the boundaries of genomic sequencing. Together, we are all #Illuminaproud #sequenceme #inspired

  • NGS is changing the landscape of cancer diagnostics. Dive into experts' opinions about these changes. #genomics #oncology

  • In support of breast cancer awareness, our Korea team and their families took part in PINKRUN SEOUL 2019. The event, which also aims to increase awareness of screening through genetic testing, saw our employees and their families bonding in a 3km and 10km run. At Illumina, our employees are eligible for paid volunteer time to give back to their communities. #IlluminaCares #IlluminaAPAC

  • At Illumina, we collaborate on and off the field! Our in-house recreation leagues are open to all full time employees. It's a great opportunity to network across the company! Join the the team - #lifeatillumina

Work at Illumina? Share Your Experiences

  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate